Institutional members access full text with Ovid®

New Oral Contraceptive Approved

Aschenbrenner, Diane S. MS, APRN-BC

AJN, American Journal of Nursing: September 2010 - Volume 110 - Issue 9 - pp 28-29
doi: 10.1097/01.NAJ.0000388260.26557.32
Drug Watch

* Natazia is a newly approved oral contraceptive that has four phases of estrogen and progestin strengths.

* Natazia shouldn't be prescribed for patients taking inducers of the CYP3A4 isoenzyme.

Diane S. Aschenbrenner is the course coordinator for undergraduate pharmacology at Johns Hopkins University School of Nursing in Baltimore, MD. She also coordinates Drug Watch:

© 2010 Lippincott Williams & Wilkins, Inc.